MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
温馨提示:MGCD-265 (Glesatinib),品质稳定,纯度>98+%,仅供实验使用.产品质量严格控制,保证品质。
南京百鑫德诺生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!